跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MESALAZINE SCP mesalazine 1.2 g gastro-resistant prolonged release tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
MESALAZINE SCP mesalazine 1.2 g gastro-resistant prolonged release tablet bottle
Approved
STANDARD
MESALAZINE SCP mesalazine 1.2 g gastro-resistant prolonged release tablet bottle
Southern Cross Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
d97f564e6a239a16
Company
Southern Cross Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
d97f564e6a239a16
Product Name
MESALAZINE SCP mesalazine 1.2 g gastro-resistant prolonged release tablet bottle
Artg Id
310312
Artg Name
MESALAZINE SCP mesalazine 1.2 g gastro-resistant prolonged release tablet bottle
Sponsor
Southern Cross Pharma Pty Ltd
Company Detail Path
/organization/southern-cross-pharma-pty-ltd
Artg Date
2021-09-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
d97f564e6a239a16
Type
Standard
Back to TGA Approvals